Adverse events causing discontinuation of donepzil for Alzheimer's dementia;Bivirkninger som årsag til seponering af donepezil ved Alzheimers demens

Ugeskrift for Laeger

Volumn 171, Issue 50, 2009, Pages

  Carøe, Tanja Korfitsen ^a   Moe, Claus ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

AGED; ALZHEIMER DISEASE; APPETITE; ARTICLE; CHEMICALLY INDUCED DISORDER; DIARRHEA; DRUG EFFECT; FEMALE; HUMAN; MALE; NAUSEA; RETROSPECTIVE STUDY; VOMITING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APPETITE; CHOLINESTERASE INHIBITORS; DIARRHEA; FEMALE; HUMANS; INDANS; MALE; NAUSEA; NOOTROPIC AGENTS; PIPERIDINES; RETROSPECTIVE STUDIES; VOMITING;

EID: 73949138448     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Demens - den fremtidige tilrettelæggelse af sundhedsvæsenets indsats vedrørende diagnostik og behandling. København: Sundhedsstyrelsen, 2001.
2. Waldemar G, Bruhn P, Dam A M et al. Referenceprogram for demensudredning. København: Dansk neurologisk selskab, 1998.
3. Rogers SL, Farlow MR, Doody RS et al. A 24-week, double-blind, placebo-controlled trail of donepezil inpatients with Alzheimer's disease. Neurology 1998;50:136-45.
4. Rogers SL, Farlow MR, Doody RS et al. Donepezil improves cognition and global function in Alzheimer disease. Arch Int Med 1998;158:1021-31.
5. Burns A, Rossor M, Hecker J et al. The effects of Donepezil in Alzheimer's disease - results from a multinational trail. Dementia Geriatr Cogn Disord 1999;10:237-44.
6. Moe C. Demens - diagnostik og behandling på en geriatrisk hukommelsesenhed. Ugeskr læger 2006;168:2167-71.